Forbion is a leading European venture capital firm specializing in life sciences and biotech, investing across early and growth stages. The firm brings deep expertise in drug development, clinical trials, and regulatory strategy, and typically engages in long-term, capital-intensive company building. Forbion is highly relevant for biotech founders with serious scientific assets, and irrelevant for general tech, SaaS, or consumer startups.